Abstract
Papovaviruses are small, nonenveloped DNA viruses that share certain morphological features and replicative processes. The term “papova” is an acronym composed by grouping the first two letters of “human papilloma. virus,” “mouse polyoma virus,” and “simian vacuolating virus” (simian virus 40, SV40) (Melnick, 1962). The papovaviruses fall naturally into two subgroups: the larger papilloma (wart) viruses, which produce benign tumors of the skin or mucous membrane, and the smaller viruses of the SV40-polyoma subgroup, most of which cause infections of the urinary tract and are oncogenic for laboratory animals. It has been proposed that the papovaviruses be established taxonomically as a family, Papovaviridae, containing two genera, Papovavirus A (the papillomaviruses) and Papovavirus B (viruses of the SV40-polyoma subgroup), and that virus species be designated by numbers (Melnick et al., 1974). Papovavirus infections of man and their chief characteristics are listed in Table 1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abcarian, H., Smith, D., and Sharon, N., 1976, The immunotherapy of anal condyloma acuminatum, Dis. Colon Rectum 19:237–244.
Almeida, J. D., and Goffe, A. P., 1965, Antibody to wart virus in human sera demonstrated by electron microscopy and precipitin tests. Lancet 2:1205–1207.
Almeida, J. D., Oriel, J. D., and Stannard, L. M., 1969, Characterization of the virus found in human genital warts, Microbios 3:225–232.
Astrom, K. E., Mancall, E. L., and Richardson, E. P., Jr., 1958, Progressive multifocal leukoencephalopathy: A hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin’s disease.Brain 81:93–111.
Belhsario, J. C., 1971, Treatment of warts with smallpox vaccine, Med. J. Aust. 2:1277–1280.
Biberstein, H., 1944, Immunization therapy of warts. Arch. Dermatol. Syphilol. 50:12–22.
Black, P. H., 1968, The oncogenic DNA viruses: A review of in vitro transformation studies, Annu. Rev. Microbiol. 22:391–426.
Boiron, M., Levy, J. P., Thomas, T., Friedmann, J. C., and Bernard, J., 1964, Some properties of bovine papilloma virus. Nature (London) 201:423–424.
Brandner, G., Burger, A., Neumann-Haeselin, D., Rinke, C., and Helwig, H., 1977, Isolation of simian virus 40 from a newborn child, J. Clin. Microbiol. 5:250–252.
Brodersen, I., Genner, J., and Brodthagen, H., 1974, Tuberculin sensitivity in BCG-vaccinated children with common warts. Acta Derm. Venereol. 54:291–292.
Brown, P., Tsai, T., and Gajdusek, D. C., 1975, Seroepidemiology of human papovaviruses: Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world.Am. J. Epidemiol. 102:331–340.
Buschke, A., and Loewenstein, L., 1932, Ueber die Beziehung von Spitzen kondylomen zu Carcinomen des Penis, Dtsch. Med. Wochenschr. 58:809–812.
Butel, J. S., 1972, Studies with human papilloma virus modeled after known papovavirus systems, N. Natl. Cancer Inst. 48:285–299.
Castaigne, P., Rondot, P., Escourolle, R., Dumas, J.-L., Ribadeau, R., Cathala, F., and Hauw, J.-J., 1974, Leu- coencephalopathie multifocale progressive et “gliomes” multiples. Rev. Neurol. 130:379–392.
Ciuffo, G., 1907, Innesto positivo con filtrato di verruca volgare, G. Ital. Mai Venereol. 48:12–17.
Coleman, D. V., 1975, The cytodiagnosis of human Polyomavirus infection. Acta Cytol. 19:93–95.
Coleman, D. V., Field, A. M., Gardner, S. D., Porter, K. A., and Starzl, T. E., 1973, Virusinduced obstruction of the ureteric and cystic duct in allograft recipients. Transplant. Proc. 5:95–98.
Cook, T. A., Cohn, A. M., Brunschwig, J. P., Goepfert, H., Butel, J. S., and Rawls, W. E., 1973, Laryngeal papilloma: Etiologic and therapeutic considerations, Ann. Otol. Rhinol. Laryngol. 82:649–655.
Coralhni, A., Barbanti-Brodano, G., Portolani, M., Bal- boni, P. G., Grossi, M. P., Possati, L., Honorati, C., LaPlace, M., Mazzoni, A., Caputo, A., Veronesi, U., Orefice, S., and Cardinah, G., 1976, Antibodies to BK virus structural and tumor antigens in human sera from normal persons and from patients with various diseases, including neoplasia, Infect. Immun. 13:1684–1691.
Cormia, F. E., 1934, Autolysate therapy for verruca vulgaris, Arch. Dermatol. Syphilol. 30:44–48.
Crawford, L. V., 1965, A study of human papilloma virus DNA, J. Mol. Biol. 13:362–372.
Crawford, L. V., 1973, Proteins of polyoma virus and SV40, Br. Med. Bull. 29:253–258.
Crawford, L. V., and Black, P. H., 1964, The nucleic acid of simian virus 40, Virology 24:388–392.
Cubie, H., 1972, Serological studies in a student population prone to infection with human papilloma virus, J. Hyg. 70:677–690.
Davies, S. W., 1965, Giant condylomata acuminata: Incidence among cases diagnosed as carcinoma of the penis, J. Clin. Pathol. 18:142–149.
Delap, R., Friedman-Kien, A., and Rush, M. G., 1976, The absence of human papilloma viral DNA sequences in condylomata acuminata.Virology 74:268–272.
Dougherty, R. M., 1976, A comparison of human papovavirus T antigens, J. Gen. Virol. 33:61–70.
Eisinger, M., Kucarova, O., Sarkar, N. H., and Good, R. A., 1975, Propagation of human wart virus in tissue culture, Nature (London) 256:432–434.
Estes, M. K., Huang, E., and Pagano, J., 1971, Structural polypeptides of simian virus 40, J. Virol. 7:635–641.
Favre, M., Orth, G., Croissant, O., and Yaniv, M., 1975a, Human papilloma virus DNA: Physical map, Proc. Natl. Acad. Sci. USA 72:4810–4814.
Favre, M., Breitburd, F., Croissant, O., and Orth, G., 1975b, Structural polypeptides of rabbit, bovine and human papillovaviruses, J. Virol. 15:1239–1247.
Ferguson, J., and Davis, R. W., 1975, An electron microscopic method for studying and mapping the region of weak sequence homology between simian virus 40 and polyoma DNAs, J. Mol. Biol. 94:135–149.
Fiori, M., and diMayorca, G., 1976, Occurrence of BK virus DNA in DNA obtained from certain human tumors, Proc. Natl. Acad. Sci. USA 73:4662–4666.
Fitzgerald, D. M., and Hanit, H. F., 1974, The variable significance of condylomata acuminata, Ann. Surg. 179:328–331.
Friedman, J. M., and Fialkow, P. J., 1976, Viral “tumorigenesis” in man: Cell markers in condylomata acuminata, Int. J. Cancer 17:57–61.
Gardner S. D., 1977, The new human papovaviruses: Their nature and significance, in: Recent Advances in Clinical Virology (A. P. Waterson, ed.), pp. 93–115, Churchill Livingstone, Edinburgh.
Gardner, S. D., Field, A. M., Coleman, D. V., and Hulme, B., 1971, New human papovavirus (B.K.) isolated from urine after renal transplantation, Lancet 1:1253–1257.
Gissmann, L., and zur Hausen, H., 1976, Human papilloma virus DNA: Physical mapping and genetic heterogeneity, Proc. Natl. Acad. Sci. USA 73:1310–1313.
Gissmann, L., Pfister, H., and zur Hausen, H., 1977, Human papilloma virus (HPV): Characterization of four different isolates. Virology 76:569–580.
Glinski, W., Jablonska, S., Langner, A., Obalek, S., Haftek, M., and Proniewska, M., 1976, Cell-mediated immunity in epidermodysplasia verruciformis. Dermatologica 153:218–227.
Goffe, A. P., Almeida, J. D., and Brown, F., 1966, Further information on the antibody response to wart virus. Lancet 2:607–609.
Gordon, D. E., and Olson, C., 1968, Meningeomas and fibroblastic neoplasia in calves induced with the bovine papilloma virus, Cancer Res. 28:2423–2431.
Greenberg, J. H., Smith, T. L., and Katz, R. M., 1973, Verrucae vulgaris rejection. Arch. Dermatol. 107:580–582.
Gribble, D. H., Haden, C. C., Schwartz, L. W., and Henrickson, R. V., 1975, Spontaneous progressive multifocal leukoencephalopathy (PML) in macaques. Nature (London) 254:602–604.
Heinonen, O. P., Shapiro, S., Monson, R., Hartz, S., Rosenberg, L., and Slone, D., 1973, Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int. J. Epidemiol. 2:229–235.
Helin, P., and Bergh, M., 1975, Levamisole for warts, N. Engl. J. Med. 291:1311.
Ho, M., Suwansirikul, S., Dowling, J. N., Youngblood, I. A., and Armstrong, J. A., 1975, The transplanted kidney as a source of cytomegalovirus infection, N. Engl. J. Med. 293:1109–1112.
Holmberg, C., Gribble, D. M., Takemoto, K., Howley, P., Espana, C., and Osborn, B. I., 1977, Isolation of simian virus 40 from progressive multifocal encephalopathy in rhesus monkeys, J. Infect. Dis. 136: 543–546.
Israel, R. M., 1969, Treatment of warts by vaccination. Arch. Dermatol. 100:222–223.
Ivanyi, L., and Morison, W. L., 1976, In vitro lymphocyte stimulation by wart antigen in man, Br. J. Dermatol. 94:523–527.
Jablonska, S., and Formas, I., 1959, Weitere positive Ergelnisse mit Auto- und Heteroinokulation bei Epidermodysplasia verruciformis Lewandowsky-Lutz, Dermatologica 118:86–93.
Jung, M., Krech, U., Price, P. C., and Pyndiah, M. N., 1975, Evidence of chronic persistent infections with polyomaviruses (BK type) in renal transplant recipients. Arch. Virol. 47:39–46.
Kelly, T. J., Jr., and Nathans, D., 1977, The genome of simian virus 40, Adv. Virus Res. 21:85–173.
Klein, E., 1972, Chemotherapy and immunotherapy for cancer involving the skin, in: Seventh National Cancer Conference Proceedings, pp. 567–578, Lippincott, Philadelphia.
Krauss, F. T., and Perez-Mesa, C., 1966, Verrucous carcinoma, Cancer 19:26–38.
Kreider, J. W., 1963, Studies on the mechanism responsible for the spontaneous regression of the Shope rabbit papilloma, Cancer Res. 23:1593–1599.
Lancaster, W. D., and Meinke, W., 1975, Persistence of viral DNA in human cell cultures infected with human papilloma virus. Nature (London) 256:434–436.
Lancaster, W. D., Olson, C., and Meinke, W., 1977, Bovine papilloma virus: Presence of virus-specific DNA sequences in naturally occurring equine tumors, Proc. Natl. Acad. Sci. USA 74:524–528.
le Bouvier, G. L., Sussman, M., and Crawford, L. V., 1966, Antigenic diversity of mammalian papillomaviruses, J. Gen. Microbiol. 45:497–501.
Lee, A. K. Y., and Eisinger, M., 1976, Cell-mediated immunity (CMI) to human wart virus and wart-associated tissue antigens, Clin. Exp. Immunol. 26:419–424.
Lewandowsky, F., and Lutz, W., 1922, Ein fall einer bisher nicht beschriebenen hauterkrankung (epidermodysplasia verruciformis). Arch. Dermatol. Syph. 141:193–203.
Lewis, H. M., 1973, Topical immunotherapy of refractory warts. Cutis 12:863–866.
Maderna, C., 1934, La intradermoreazione con antigene specifico in infermi affetti do condilomi acuminati. Riforma Med. 50:1604–1611.
Maderna, C., 1935, La deviazione del complemento in infermi affetti da condilomi acuminati.Riforma Med. 51:93–94.
Mason, D. H., Jr., and Takemoto, K. K., 1977, Transformation of rabbit kidney cells by BKV (MM) human papovavirus, Int. J. Cancer 19:391–395.
Massing, A. M., and Epstein, W. L., 1963, Natural history of warts: A two year study. Arch. Dermatol. 87:306–310.
Matthews, R. S., and Shirodaria, P. V., 1973, Study of regressing warts by immunofluorescence. Lancet 1:689–691.
McGee, A. R., 1967, Apparent antagonism of vaccinia and wart viruses.Cancer 20:1647–1653.
Melnick, J. L., 1962, Papova virus group. Science 135:1128–1130.
Melnick, J. L., and Rapp, F., 1965, Possible relationship between two primate papovaviruses, human wart and simian SV40, J. Natl. Cancer Inst. 34:529–534.
Melnick, J. L., Allison, A. C., Butel, J. S., Eckhart, W., Eddy, B. E., Kit, S., Levine, A. J., Miles, J. A. R., Pagaono, J. S., Sachs, L., and Vonka, V., 1974, Papovaviridae, Intervirology 3:106–120.
Morison, W. L., 1974, In vitro assay of cell-mediated immunity to human wart antigen, Br. J. Dermatol. 90:531–534.
Morison, W. L., 1975a, In vitro assay of immunity to human wart antigen, Br. J. Dermatol. 93:545–551.
Morison, W. L., 1975b, Cell-mediated immune responses in patients with warts, Br. J. Dermatol. 93:553–556.
Murray, R. F., Hobbs, J., and Payne, B., 1971, Possible clonal origin of common warts (Verrucae vulgaris). Nature (London) 232:51–52.
Niimura, M., Pass, F., Wooley, R., and Soutor, C. A., 1975, Primary tissue culture of human wart-derived epidermal cells (keratinocytes), J. Natl. Cancer Inst. 54:563–569.
Ogilvie, M. M., 1970, Serological studies with human papova (wart) virus, J. Hyg. 68:479–490.
Oleske, J. M., and Kushnick, T., 1971, Juvenile papilloma of the larynx. Am. J. Dis. Child. 121:417–419.
Olson, C., Segre, D., and Skidmore, L. V., 1959, Immunity to bovine cutaneous papillomatosis produced by vaccine homologous to the challenge agent, J. Am. Vet. Med. Assoc. 135:499–502.
Oriel, J. D., 1971, Natural history of genital warts, Br. J. Vener. Dis. 47:1–8.
Padgett, B. L., and Walker, D. L., 1973, Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy, J. Infect. Dis. 127:467–470.
Padgett, B. L., and Walker, D. L., 1976, New human papovaviruses, Prog. Med. Virol. 22:1–35.
Padgett, B. L., Walker, D. L., ZuRhein, G. M., Eckroade, R. J., and Dessel, B. H., 1971, Cultivation of papovalike virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1:1257–1260.
Padgett, B. L., Hunt, J. M., and Walker, D. L., 1977, Specificity of the tumor-specific transplantation antigen induced by JC virus, a hyman polyoma-virus, Intervirology 8:182–185.
Pass, F., and Maizel, J. V., Jr., 1973, Wart-associated antigens. II. Human immunity to viral structural proteins, J. Invest. Dermatol. 60:307–311.
Pass, F., and Marcus, D. M., 1973, Wart-associated antigens. I. Isolation of tissue antigens using antibody immunoadsorbents, J. Invest. Dermatol. 60:301–305.
Pass, F., Janis, R., and Marcus, D. M., 1971, Antigens of human wart tissue, J. Invest. Dermatol. 56:305–310.
Pass, F., Reissig, M., Shah, K. V., Eisinger, M., and Orth, G., 1977, Identification of an immunologically distinct papillomavirus from lesions of epidermodysplasia verruciformis, J. Natl. Cancer Inst. 59:1107–1112.
Perry, T. L., and Harman, L., Jr., 1974, Warts in diseases with immune defects. Cutis 13:359–362.
Portolani, M., Barbanti-Brodano, G., and LaPlaca, M., 1975, Malignant transformation of hamster kidney cells by BK virus, Virol. 15:420–422.
Powell, L. C., Pollard, M., and Jinkins, J. L., 1970, Treatment of condyloma acuminata by autogenous vaccines. South. Med. J. 63:202–205.
Prawer, S. E., Pass, F., Vance, J. C., Greenberg, L. J., Yunis, E. J., and Zelickson, A. S. 1977, Depressed immune function in epidermodysplasia verruciformis. Arch. Dermatol. 113:495–499.
Pyrhonen, S., 1976, Serological aspects of the immunology of human warts, in: Biomedical Aspects of Human Wart Virus Infection (M. Prunieras, ed.), pp. 191–198, Fondation Merieux, Lyon.
Pyrhonen, S., and Johansson, E., 1975, Regression of warts. An immunologic study, Lancet 1:592–595.
Pyrhonen, S., and Penttinen, K., 1972, Wart-virus antibodies and the prognosis of wart disease, Lancet 2:1330–1332.
Rasmussen, K. A., 1958, Verrucae plantares: Symptomatology and epidemiology. Acta Derm. Venereol. 38:1–146 (Suppl. 39).
Reese, J. M., Reissig, M., Daniel, R. W., and Shah, K. v., 1975, Occurrence of BK virus and BK virus-specific antibodies in the urine of patients receiving chemotherapy for malignancy. Infect. Immun. 11:1375–1381.
Reissig, M., Kelly, T. J., Jr., Daniel, R. W., Rangan, S. R. S., and Shah, K. V., 1976, Identification of the stumptailed macaque virus as a new papovavirus. Infect. Immun. 14:225–231.
Renoux, G., Renoux, M., and Geullaumin, J. M., 1976, Mechanismes d’action du levamisole ou du diethyldithiocarbamate de soude dans la stimulation des responses immunes, in: Biomedical Aspects of Human Wart Virus Infection (M. Prunieras, ed.), pp. 273–286, Fondation Merieux, Lyon.
Reuter, M., and van-Mullen, P. J., 1970, Behavior of virus in malignant degeneration of skin lesions in epidermodysplasia verruciformis, J. Invest. Dermatol. 54:324–331.
Richardson, E. P., Jr., 1961, Progressive multifocal leukoencephalopathy, N. Engl. J. Med. 265:815–823.
Richardson, E. P., and Johnson, P. C., 1975, Atypical progressive multifocal leukoencephalopathy with plasma cell infiltrates. Acta Neuropathol, Suppl. 6:247–250.
Rous, P., and Friedewald, W. F., 1944, The effect of chemical carcinogens on virus-induced rabbit papillomas, J. Exp. Med. 79:511–537.
Rowson, K. E. K., and Mahy, B. W. J., 1967, Human papova (wart) virus, Bacteriol. Rev. 31:110–121.
Ruhson, R. H., 1942, Warts. A statistical study of nine hundred and twenty-one cases, Arch. Dermatol. Syphilol. 46:66–81.
Shah, K. v., 1972, Evidence for an SV40-related papovavirus infection of man.Am. J. Epidemiol. 95:199–206.
Shah, K. v., and Hess, D. M., 1968, Presence of antibodies to simian-virus 40 (SV40) T antigen in rhesus monkeys infected experimentally or naturally with SV40, Proc. Soc. Exp. Biol. Med. 128:480–485.
Shah, K. v., and Nathanson, N., 1976, Human exposure to SV40: Review and comment. Am. J. Epidemiol. 103:1–12.
Shah, K. v., Daniel, R. W., and Murphy, G., 1973a, Antibodies reacting to simian-virus 40 T antigen in human sera, J. Natl. Cancer Inst. 51:687–690.
Shah, K. v., Daniel, R. W., and Warszawski, R., 1973b, High prevalence of antibodies to BK virus, and SV40 related papovavirus, in residents of Maryland, J. Infect. Dis. 128:784–787.
Shah, K. v., Hudson, C., Vahs, J., and Strandberg, J. D., 1976, Experimental infection of human foreskin cultures with BK virus, a human papovavirus, Proc. Soc. Exp. Biol. Med. 153:180–186.
Shah, K. v., Ozer, H. I., Ghazey, H. N., and Kelly, T. J., Jr., 1977, Common structural antigen of papovaviruses of the simian virus 40-polyoma subgroup, J. Virol. 21:179–186.
Shirodaria, P. V., and Matthews, R. S., 1975, An immunofluorescence study of warts, Clin. Exp. Immunol. 21:329–338.
Sims, C. F., and Garb, J., 1951, Giant condylomata acuminata of the penis associated with metastatic carcinoma of the right inguinal lymph node. Arch. Dermatol. 63:383–385.
Soriano, F., Shelburne, C. E., and Gokcen, M., 1974, Simian virus 40 in a human cancer. Nature (London) 249:421–424.
Spencer, E. S., and Andersen, H. K., 1970, Clinical evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients, Br. Med. J. 3:251–254.
Stevens, D. A., Ferrington, R. A., Merigan, T. C., and Marinkovich, V. A., 1975, Randomized trial of transfer factor treatment of human warts, Clin. Exp. Immunol. 21:520–524.
Strauss, M. J., Shaw, E. W., Bunting, H., and Melnick, J. L., 1949, “Crystalline” virus-like particles from skin papillomas characterized by intranuclear inclusion bodies, Proc. Soc. Exp. Biol. Med. 72:46–50.
Sweet, B. H., and Hilleman, M. R., 1960, The vacuolating virus, SV4D, Proc. Soc. Exp. Biol. Med. 105:420–427.
Syverton, J. T., 1952, The pathogenesis of the rabbit papilloma to carcinoma sequence, Ann. N.Y. Acad. Sci. 54:1126–1140.
Tagami, H., Ogino, A., Takigawa, M., Imamura, S., and Ofugi, S., 1974, Regression of plane warts following spontaneous inflammation, Br. J. Dermatol. 90:147–154.
Takemoto, K. K., and Martin, M. A., 1976, Transformation of hamster kidney cells by BK papovavirus DNA, J. Virol. 17:247–253.
Takemoto, K. K., and Mullarkey, M. F., 1973, Human papovavirus, BK strain: Biological studies including antigenic relationship of simian virus 40, J. Virol. 12:625–631.
Takemoto, K. K., Rabson, A. S., Mullarkey, M. F., Blaese, R. M., Garon, C. F., and Nelson, D., 1974, Isolation of papovavirus from brain tumor and urine of a patient with Wiskott-Aldrich syndrome, J. Natl. Cancer Inst. 53:1205–1207.
Valis, J. D., Newell, N., Reissig, M., Malherbe, H., Kaschula, v., and Shah, K. V., 1977, Characterization of SA12 as an SV40-related papovavirus of the chacma baboon.Infect. Immun. 18:247–252.
Waisman, M., 1975, Epidermodysplasia verruciformis: A retrospective glance and current appraisal, Cutis 16:627–632.
Weiner, L. P., and Narayan, O., 1974, Virologic studies of progressive multifocal leukoencephalopathy. Prog. Med. Virol. 18:229–240.
Weiner, L. P., Herndon, R. M., Narayan, O., Johnson, R. T., Shah, K. V., Rubinstein, L. J., Preziosi, T. J., and Conley, F. K., 1972, Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy, N. Engl. J. Med. 286:385–390.
Weiss, A. F., Portmann, R., Fischer, H., Simon, J., Jr., and Zang, K. D., 1975, Simian virus 40-related antigens in three human meningiomas with defined chromosome loss, Proc. Natl. Acad. Sci. USA 72:609–613.
zur Hausen, H., Meinhof, W., Scheiber, W., and Bornkamm, G. W., 1974, Attempts to detect virus-specific DNA in human tumors. I. Nuclei acid hybridizations with complementary RNA of human wart virus. Int. J. Cancer 13:650–656.
ZuRhein, G. M., 1969, Association of papova-virions with a human demyelinating disease (progressive multifocal leukoencephalopathy). Prog. Med. Virol. 11:185–247.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Publishing Corporation
About this chapter
Cite this chapter
Pass, F., Shah, K.V. (1982). Immunology of Human Papovaviruses. In: Nahmias, A.J., O’Reilly, R.J. (eds) Immunology of Human Infection. Comprehensive Immunology, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1012-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1012-9_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1014-3
Online ISBN: 978-1-4684-1012-9
eBook Packages: Springer Book Archive